These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 3155275)
1. A new topical antibacterial agent. Watt B Microbiol Sci; 1987 Nov; 4(11):336-7. PubMed ID: 3155275 [No Abstract] [Full Text] [Related]
2. [Comparative double-blind evaluation of a new topical antibacterial agent, mupirocin, compared with placebo in the treatment of skin and soft tissue infections]. Colin M; Avon P Pharmatherapeutica; 1988; 5(3):198-203. PubMed ID: 3129741 [TBL] [Abstract][Full Text] [Related]
5. Clinical and bacteriological efficacy of mupirocin (Bactroban): a new topical antibiotic. Gould PW; Villiger JW N Z Med J; 1986 Jul; 99(805):516. PubMed ID: 3090486 [No Abstract] [Full Text] [Related]
6. Mupirocin (2 percent) ointment in the treatment of primary and secondary skin infections. Odom RB Cutis; 1989 Jun; 43(6):599-601. PubMed ID: 2501071 [TBL] [Abstract][Full Text] [Related]
7. Mupirocin--a new topical antibiotic. Med Lett Drugs Ther; 1988 May; 30(766):55-6. PubMed ID: 3129636 [No Abstract] [Full Text] [Related]
9. Topical mupirocin versus topical neosporin in the treatment of cutaneous infections. Wilkinson RD; Carey WD Int J Dermatol; 1988 Sep; 27(7):514-5. PubMed ID: 2851560 [No Abstract] [Full Text] [Related]
10. Topical mupirocin in the treatment of bacterial skin infections. Rumsfield J; West DP; Aronson IK Drug Intell Clin Pharm; 1986 Dec; 20(12):943-8. PubMed ID: 3102197 [TBL] [Abstract][Full Text] [Related]
12. Statistically evaluated clinical observations from a multicentre study on the activity of a new topical antimicrobial and antimycotic agent in paediatric skin diseases. Allegra F; Cainelli T; Csermely E; Gelmetti C; Gandola M; Martina G; Santini R; Tomasini C; Zanca A Panminerva Med; 1978; 20(4):239-49. PubMed ID: 755971 [No Abstract] [Full Text] [Related]
13. Mupirocin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Ward A; Campoli-Richards DM Drugs; 1986 Nov; 32(5):425-44. PubMed ID: 3098541 [TBL] [Abstract][Full Text] [Related]
14. Topical 2% mupirocin versus 2% fusidic acid ointment in the treatment of primary and secondary skin infections. Gilbert M J Am Acad Dermatol; 1989 Jun; 20(6):1083-7. PubMed ID: 2502567 [TBL] [Abstract][Full Text] [Related]
15. A comparison of the new topical antibiotic mupirocin ('Bactroban') with oral antibiotics in the treatment of skin infections in general practice. Villiger JW; Robertson WD; Kanji K; Ah Chan M; Fetherston J; Hague IK; Haycock D; Hunter P Curr Med Res Opin; 1986; 10(5):339-45. PubMed ID: 3102167 [TBL] [Abstract][Full Text] [Related]
16. An evaluation of topical mupirocin in moderately severe primary and secondary skin infections. Buchvald J J Int Med Res; 1988; 16(1):66-70. PubMed ID: 3127257 [TBL] [Abstract][Full Text] [Related]
17. Mupirocin in the treatment of impetigo. Infectious Diseases and Immunization Committee, Canadian Paediatric Society. CMAJ; 1990 Mar; 142(6):543-4. PubMed ID: 2107019 [No Abstract] [Full Text] [Related]
18. Topical antibiotics in the treatment of superficial skin infections in general practice--a comparison of mupirocin with sodium fusidate. White DG; Collins PO; Rowsell RB J Infect; 1989 May; 18(3):221-9. PubMed ID: 2501394 [TBL] [Abstract][Full Text] [Related]